KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Amgen (AMGN) Shares Outstanding (Weighted Average) (2016 - 2025)

Historic Shares Outstanding (Weighted Average) for Amgen (AMGN) over the last 17 years, with Q3 2025 value amounting to $538.0 million.

  • Amgen's Shares Outstanding (Weighted Average) rose 18.62% to $538.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $538.0 million, marking a year-over-year increase of 18.62%. This contributed to the annual value of $537.0 million for FY2024, which is 37.38% up from last year.
  • Latest data reveals that Amgen reported Shares Outstanding (Weighted Average) of $538.0 million as of Q3 2025, which was up 18.62% from $538.0 million recorded in Q2 2025.
  • In the past 5 years, Amgen's Shares Outstanding (Weighted Average) ranged from a high of $577.0 million in Q1 2021 and a low of $534.0 million during Q1 2023
  • Its 5-year average for Shares Outstanding (Weighted Average) is $545.3 million, with a median of $538.0 million in 2022.
  • Per our database at Business Quant, Amgen's Shares Outstanding (Weighted Average) plummeted by 591.3% in 2022 and then soared by 37.45% in 2024.
  • Over the past 5 years, Amgen's Shares Outstanding (Weighted Average) (Quarter) stood at $570.0 million in 2021, then fell by 5.61% to $538.0 million in 2022, then decreased by 0.56% to $535.0 million in 2023, then increased by 0.37% to $537.0 million in 2024, then rose by 0.19% to $538.0 million in 2025.
  • Its last three reported values are $538.0 million in Q3 2025, $538.0 million for Q2 2025, and $538.0 million during Q1 2025.